The groundbreaking rise of Viagra has long been a benchmark of pharmaceutical success, but its position within the broader sector now raises questions about future gains. Alternative versions are diminishing exclusivity , leading to concerns that supporting companies significantly dependent to Viagra's once-dominant more info influence could be a p